Mahdavi Gorabi, A., Banach, M., Reiner, Ž., Pirro, M., Hajighasemi, S., Johnston, T. P. & Sahebkar, A. (2019). The role of mesenchymal stem cells in atherosclerosis: prospects for therapy via the modulation of inflammatory milieu. Journal of Clinical Medicine, 8. (9). doi: 10.3390/jcm8091413
Mahdavi Gorabi, Armita, et al. "The role of mesenchymal stem cells in atherosclerosis: prospects for therapy via the modulation of inflammatory milieu." Journal of Clinical Medicine, vol. 8, no. 9, 2019. https://doi.org/10.3390/jcm8091413
Mahdavi Gorabi, Armita, Maciej Banach, Željko Reiner, Matteo Pirro, Saeideh Hajighasemi, Thomas P. Johnston and Amirhossein Sahebkar. "The role of mesenchymal stem cells in atherosclerosis: prospects for therapy via the modulation of inflammatory milieu." Journal of Clinical Medicine 8, no. 9 (2019). https://doi.org/10.3390/jcm8091413
Mahdavi Gorabi, A., et al. (2019) 'The role of mesenchymal stem cells in atherosclerosis: prospects for therapy via the modulation of inflammatory milieu', Journal of Clinical Medicine, 8(9). doi: 10.3390/jcm8091413
Mahdavi Gorabi A, Banach M, Reiner Ž, Pirro M, Hajighasemi S, Johnston TP, and sur.. The role of mesenchymal stem cells in atherosclerosis: prospects for therapy via the modulation of inflammatory milieu. Journal of Clinical Medicine [Internet]. 2019 September 08 [cited 2024 November 30];8(9). doi: 10.3390/jcm8091413
A. Mahdavi Gorabi, et al., "The role of mesenchymal stem cells in atherosclerosis: prospects for therapy via the modulation of inflammatory milieu", Journal of Clinical Medicine, vol. 8, no. 9, September 2019. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:669618. [Accessed: 30 November 2024]